NCT04106336

UnknownEarly Phase 1

Cortical Excitability and Role of rTMS in Cannabis Use Disor...

Assiut University Source

Compare

Other study identifiers

Sponsor study identifier

rTMS in cannabis use disorder

Study Type

interventional

Estimated enrollment

60

Locations

0 countries

Sites

N/A

Timeline

Study Start

October 1, 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

October 1, 2020

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

December 30, 2020

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

Repetitive transcranial magnetic stimulation (rTMS) and cortical excitability have a role in cannabis use disorder

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 60 participants
Study completion date: December 30, 2020
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
September 23, 2019
Actual (reported)
First Posted
September 27, 2019
Actual (reported)
Study Start
October 1, 2019
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
October 1, 2020
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 30, 2020
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: September 27, 2019
Status Verified: September 2019
Last Update Submitted: September 25, 2019

Conditions

Cannabis Use Disorder, Moderate

Outcome Measures

Primary Outcomes (1)

Determination of role of rTMS for reducing cannabis craving
Incidenc of cannabis craving after rTMS
1 year

Secondary Outcomes (1)

Estimation of cortical excitability in cannabis addict
1 year

Study Arms (2)

non cannabis addict

NO INTERVENTION

30 non cannabis addict will be control group

cannabis addict

ACTIVE COMPARATOR

30 cannabis addict will undergo rTMS

Device: rTMS

Interventions

rTMSDevice

Repetitive transcranial magnetic stimulation (rTMS) will be done for cannabis addict

cannabis addict

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 50 Years

Sexmale

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

to 50 years of age
cannabis use disorder according to DSM 5 definition

Sponsors & Collaborators

Assiut University
Otherlead

MeSH Terms

Conditions

Lymphoma, Follicular

Condition Hierarchy (Ancestors)

Lymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Design

Study Type: interventional
Phase: early phase 1
Allocation: NON RANDOMIZED
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Asmaa Omar Radwan Helal

Study Record Dates

First Submitted

September 23, 2019

First Posted

September 27, 2019

Study Start

October 1, 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

October 1, 2020

NCT03994120

Modulating the Hippocampal and Striatal Memory Networks With rTMS

Not ApplicableCompleted

NCT03892382

Repetitive Transcranial Magnetic Stimulation as Therapy for Apathy in Amyotrophic Lateral Sclerosis

Not ApplicableWithdrawn

NCT03705936

Metaplasticity in Human Pharyngeal Motor Cortex

Not ApplicableCompleted

NCT04568369

Treatment of Post-concussion Syndrome With TMS: Using FNIRS as a Biomarker of Response

Not ApplicableUnknown

NCT03538288

Feasibility Trial of rTMS for Cannabis Use Disorder

Not ApplicableCompleted

NCT03370107

Comparison of rTMS and H Coil in Neuropathic Pain

Not ApplicableCompleted

clear consent to participate in study

You may not qualify if:

cardiac peacemaker
metal implant in the head as participate will be applied to magnetic field of TMS
current intake of any medication affect cognition (as anti psychotic and anti epileptic)
current history of neurological , psychiatric or general medical disease .current or previous drug (other than cannabis )or alcohol abuse or participation in another trial during the past 8 weeks .
age younger than 18 and older than 50 years

Contact the study team to confirm eligibility.

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

December 30, 2020

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

September 27, 2019

Record last verified: 2019-09

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT04106336
Data provider: ClinicalTrials.gov
Source updated: 2019-09-27
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:21:10 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

non cannabis addict

cannabis addict

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

You may not qualify if:

Source record